Edition:
United States

ValiRx PLC (VALX.L)

VALX.L on London Stock Exchange

5.12GBp
12 Jan 2017
Change (% chg)

-0.12p (-2.38%)
Prev Close
5.25p
Open
5.25p
Day's High
--
Day's Low
--
Volume
777,820
Avg. Vol
1,275,539
52-wk High
20.70p
52-wk Low
4.69p

VALX.L

Chart for VALX.L

About

ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the... (more)
No analyst recommendations are available for VALX.L.

Overall

Beta: 1.39
Market Cap(Mil.): £4.39
Shares Outstanding(Mil.): 85.65
Dividend: --
Yield (%): --

Financials

  VALX.L Industry Sector
P/E (TTM): -- 45.92 30.50
EPS (TTM): -0.07 -- --
ROI: -91.69 -1.27 14.84
ROE: -89.37 -1.00 16.26

Earnings vs. Estimates